Caprock Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.76M | Sell |
7,978
-1,315
| -14% | -$364K | 0.03% | 440 |
|
|
2026
Q1 | $2.74M | Buy |
9,293
+3,176
| +52% | +$943K | 0.07% | 260 |
|
|
2025
Q4 | $1.67M | Buy |
6,117
+359
| +6% | +$97.6K | 0.04% | 441 |
|
|
2025
Q3 | $1.53M | Buy |
+5,758
| New | +$1.57M | 0.04% | 429 |
|
|
2025
Q1 | $1.8M | Buy |
6,803
+289
| +4% | +$71.3K | 0.06% | 323 |
|
|
2024
Q4 | $1.55M | Buy |
6,514
+434
| +7% | +$99.8K | 0.05% | 328 |
|
|
2024
Q3 | $1.34M | Buy |
6,080
+559
| +10% | +$116K | 0.05% | 324 |
|
|
2024
Q2 | $1.09M | Buy |
5,521
+540
| +11% | +$112K | 0.04% | 343 |
|
|
2024
Q1 | $1.07M | Sell |
4,981
-90
| -2% | -$18.9K | 0.06% | 232 |
|
|
2023
Q4 | $1.1M | Buy |
5,071
+194
| +4% | +$41.4K | 0.07% | 226 |
|
|
2023
Q3 | $977K | Buy |
4,877
+320
| +7% | +$63.6K | 0.07% | 212 |
|
|
2023
Q2 | $844K | Sell |
4,557
-557
| -11% | -$103K | 0.06% | 243 |
|
|
2023
Q1 | $980K | Sell |
5,114
-301
| -6% | -$54.4K | 0.08% | 204 |
|
|
2022
Q4 | $935K | Sell |
5,415
-207
| -4% | -$36K | 0.09% | 184 |
|
|
2022
Q3 | $996K | Buy |
5,622
+103
| +2% | +$20.4K | 0.1% | 153 |
|
|
2022
Q2 | $1.13M | Buy |
5,519
+295
| +6% | +$62.5K | 0.11% | 144 |
|
|
2022
Q1 | $1.24M | Buy |
5,224
+121
| +2% | +$28.4K | 0.12% | 137 |
|
|
2021
Q4 | $1.18M | Buy |
5,103
+892
| +21% | +$196K | 0.1% | 149 |
|
|
2021
Q3 | $814K | Buy |
4,211
+487
| +13% | +$98.7K | 0.07% | 190 |
|
|
2021
Q2 | $792K | Buy |
3,724
+273
| +8% | +$57.6K | 0.07% | 193 |
|
|
2021
Q1 | $705K | Sell |
3,451
-488
| -12% | -$96.1K | 0.08% | 186 |
|
|
2020
Q4 | $722K | Sell |
3,939
-316
| -7% | -$53.7K | 0.08% | 169 |
|
|
2020
Q3 | $712K | Buy |
4,255
+732
| +21% | +$123K | 0.1% | 159 |
|
|
2020
Q2 | $573K | Buy |
3,523
+1,280
| +57% | +$229K | 0.09% | 176 |
|
|
2020
Q1 | $388K | Buy |
2,243
+92
| +4% | +$18.3K | 0.07% | 189 |
|
|
2019
Q4 | $435K | Buy |
2,151
+176
| +9% | +$36.1K | 0.08% | 186 |
|
|
2019
Q3 | $417K | Buy |
1,975
+248
| +14% | +$51.8K | 0.08% | 180 |
|
|
2019
Q2 | $335K | Buy |
1,727
+345
| +25% | +$63.6K | 0.07% | 219 |
|
|
2019
Q1 | $227K | Sell |
1,382
-2,564
| -65% | -$453K | 0.04% | 312 |
|
|
2018
Q4 | $748K | Buy |
3,946
+386
| +11% | +$71.3K | 0.17% | 112 |
|
|
2018
Q3 | $606K | Sell |
3,560
-105
| -3% | -$17.7K | 0.12% | 152 |
|
|
2018
Q2 | $601K | Sell |
3,665
-121
| -3% | -$19.8K | 0.13% | 148 |
|
|
2018
Q1 | $612K | Sell |
3,786
-1,089
| -22% | -$173K | 0.13% | 144 |
|
|
2017
Q4 | $745K | Sell |
4,875
-1,457
| -23% | -$208K | 0.15% | 138 |
|
|
2017
Q3 | $859K | Buy |
6,332
+545
| +9% | +$68.8K | 0.18% | 119 |
|
|
2017
Q2 | $725K | Buy |
5,787
+50
| +0.9% | +$5.98K | 0.16% | 131 |
|
|
2017
Q1 | $682K | Buy |
5,737
+440
| +8% | +$52.9K | 0.16% | 127 |
|
|
2016
Q4 | $611K | Sell |
5,297
-3,532
| -40% | -$393K | 0.15% | 127 |
|
|
2016
Q3 | $923K | Buy |
8,829
+32
| +0.4% | +$3.34K | 0.21% | 111 |
|
|
2016
Q2 | $857K | Sell |
8,797
-267
| -3% | -$25.2K | 0.21% | 114 |
|
|
2016
Q1 | $871K | Buy |
+9,064
| New | +$825K | 0.21% | 109 |
|
Other funds holding CME
Caprock Group's CME Position: Q2 2026 in Review
Caprock Group reduced its CME Group (CME) stake by 14% in Q2 2026, selling an estimated $364K and leaving 7,978 shares worth $1.76M. The position accounts for 0.03% of the portfolio, ranked #440.
Caprock Group first reported a position in CME in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.74M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Caprock Group held 7,978 shares of CME Group worth $1.76M as of Q2 2026.
- Caprock Group sold 1,315 CME Group shares in Q2 2026, an estimated $364K.
- CME Group made up 0.03% of Caprock Group's portfolio in Q2 2026, its #440 holding.
- Caprock Group first reported a position in CME Group in Q1 2016 and has held it in 41 quarters since.
- Caprock Group's CME Group position peaked at $2.74M in Q1 2026.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.